Contemporary Diagnostics: Sarcoma Pathology Update

    loading  Checking for direct PDF access through Ovid


Sarcoma diagnosis continues to evolve as new information is discovered. Certain tumors have been downgraded (dermal leiomyosarcoma) and an atypical category designed for others. Recently entities include myxoinflammatory fibroblastic sarcoma, myoepithelioma, and pseudomyogenic hemangioendothelioma. The terms malignant fibrous histiocytoma and hemangiopericytoma are outdated. New immunostains (STAT6, SOX10, ERG) add diagnostic specificity, and new risk assessment models are described for sarcomas where grading and staging has failed to provide adequate prognosis. J. Surg. Oncol. 2015 111:513–519. © 2015 Wiley Periodicals, Inc.

Related Topics

    loading  Loading Related Articles